A prediction model of dementia conversion for mild cognitive impairment by combining plasma pTau181 and structural imaging features.

We developed and validated an accurate prediction model for dementia conversion in patients with MCI. Simultaneously, the model predicts AD-specific pathological changes. We hope that this model will contribute to more precise clinical treatment and better healthcare resource allocation.